Since 2012, just great Medicinal Chemistry...
…From a synthetic point of view.
Our mission
MEDSynth is a Medicinal Chemistry research group based at the Department of Drug Science and Technology of the University of Torino (Italy).
MEDsynth's state of the art has its roots on many years of extensive experience in the fields of drug development, more specifically our work consists in:
• Design of non-classical bioisosteric tools based on heterocyclic systems.
• Discovery of preclinical drug candidates in oncological/neglected diseases field.
• Optimisation of synthetic strategies for the production of heterocyclic scaffolds.
Moreover, our group gives much value on young scientists' formation, investing on their advanced training and betting on their future in the scientific research scenario.
MEDSynth group is able to offer a complete technological platform, from the in silico design, throughout the synthesis until the in vitro / in vivo pharmacological characterization, for the design of preclinical drug candidates.
Owing around twenty years background in Medicinal and Heterocyclic chemistry, our major research interest can be found in the design of small active molecules effective in Cancer and Neglected diseases.
At the present, MEDSynth is major focused on:
- Acute Myeloid Leukemia (AML)
- Antivirals
- Prostate Cancer and other oncological targets
-Neglected diseases (Malaria, Leishmania …)
We much value on young scientists' formation, investing on their advanced training. It consists in the following flow of knowledge:
Transfer of state-of-the-art of Drug Design labs and technologies.
Involvement in high impact oncology/neglected diseases research lines.
Involvement in the international scientific network of MEDSynth.
Tutoring, mentoring and general career support.
.png)
Copyright © 2012-2021 MEDSynth group @ Department of Science and Drug Technology
University of Torino (Italy) - All rights deserved.